Journal article
Maintenance Therapy in the Treatment of Recurrent Epithelial Ovarian Cancer
Clinical obstetrics and gynecology, Vol.63(1), pp.86-91
03/01/2020
DOI: 10.1097/GRF.0000000000000500
PMID: 31855903
Abstract
A diagnosis of recurrent epithelial ovarian cancer carries with it a very poor prognosis despite aggressive chemotherapy with or without secondary surgical cytoreduction. Recently, maintenance treatment after second-line chemotherapy has gained momentum given promising results of antiangiogenics and PARP inhibitors used in this setting. When used appropriately, these agents may provide a meaningful survival benefit with minimal effects on quality of life. This paper reveals the current literature evaluating the use of maintenance therapy in the recurrent setting for the epithelial ovarian, fallopian tube, or primary peritoneal cancers.
Details
- Title: Subtitle
- Maintenance Therapy in the Treatment of Recurrent Epithelial Ovarian Cancer
- Creators
- Colette Gnade - Department of Obstetrics and Gynecology.Megan E. Mcdonald - University of Iowa
- Resource Type
- Journal article
- Publication Details
- Clinical obstetrics and gynecology, Vol.63(1), pp.86-91
- Publisher
- Lippincott Williams & Wilkins
- DOI
- 10.1097/GRF.0000000000000500
- PMID
- 31855903
- ISSN
- 0009-9201
- eISSN
- 1532-5520
- Number of pages
- 6
- Language
- English
- Date published
- 03/01/2020
- Academic Unit
- Obstetrics and Gynecology
- Record Identifier
- 9984318324702771
Metrics
2 Record Views